Bayer AG

BAYN: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€26.00CkbsydgVpq

Bayer Earnings: Solid Results Aided by Litigation Win, Cost-Cutting, and Innovation Advancements

Bayer reported first-quarter results slightly above our expectations, but we are not making any changes to the firm’s fair value estimate. We continue to view Bayer as undervalued with the market overly concerned about litigation pressures and underappreciating the firm’s cost-cutting plan and growth potential from innovative products.

Sponsor Center